Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59.6M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
37.8M
-
Shares change
-
-1.28M
-
Total reported value, excl. options
-
$252M
-
Value change
-
-$9.93M
-
Put/Call ratio
-
1.51
-
Number of buys
-
53
-
Number of sells
-
-50
-
Price
-
$6.68
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q3 2023
148 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2023.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.8M shares
of 59.6M outstanding shares and own 63.39% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.4M shares), BlackRock Inc. (3.37M shares), VANGUARD GROUP INC (3.19M shares), STATE STREET CORP (3.07M shares), Knoll Capital Management, LLC (3.03M shares), DIMENSIONAL FUND ADVISORS LP (1.21M shares), Laurion Capital Management LP (1.13M shares), EAGLE ASSET MANAGEMENT INC (1.04M shares), GEODE CAPITAL MANAGEMENT, LLC (976K shares), and Verition Fund Management LLC (935K shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.